BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29049282)

  • 21. Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.
    Lee JD; Friedmann PD; Kinlock TW; Nunes EV; Boney TY; Hoskinson RA; Wilson D; McDonald R; Rotrosen J; Gourevitch MN; Gordon M; Fishman M; Chen DT; Bonnie RJ; Cornish JW; Murphy SM; O'Brien CP
    N Engl J Med; 2016 Mar; 374(13):1232-42. PubMed ID: 27028913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose: A Randomized Clinical Trial.
    Beaudoin FL; Jacka BP; Li Y; Samuels EA; Hallowell BD; Peachey AM; Newman RA; Daly MM; Langdon KJ; Marshall BDL
    JAMA Netw Open; 2022 Aug; 5(8):e2225582. PubMed ID: 35943744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The implementation of a naloxone rescue program in university students.
    Panther SG; Bray BS; White JR
    J Am Pharm Assoc (2003); 2017; 57(2S):S107-S112.e2. PubMed ID: 28063773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing opioid overdose in Kazakhstan: A randomized controlled trial of a couple-based integrated HIV/HCV and overdose prevention intervention "Renaissance".
    Gilbert L; Hunt T; Primbetova S; Terlikbayeva A; Chang M; Wu E; McCrimmon T; El-Bassel N
    Int J Drug Policy; 2018 Apr; 54():105-113. PubMed ID: 29414482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
    O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
    Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings.
    Winograd RP; Davis CS; Niculete M; Oliva E; Martielli RP
    Subst Abus; 2017; 38(2):135-140. PubMed ID: 28486076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid overdose and naloxone education in a substance use disorder treatment program.
    Lott DC; Rhodes J
    Am J Addict; 2016 Apr; 25(3):221-6. PubMed ID: 27002783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid overdose prevention with intranasal naloxone among people who take methadone.
    Walley AY; Doe-Simkins M; Quinn E; Pierce C; Xuan Z; Ozonoff A
    J Subst Abuse Treat; 2013 Feb; 44(2):241-7. PubMed ID: 22980450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial.
    Lee JD; McDonald R; Grossman E; McNeely J; Laska E; Rotrosen J; Gourevitch MN
    Addiction; 2015 Jun; 110(6):1008-14. PubMed ID: 25703440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs.
    Oliva EM; Nevedal A; Lewis ET; McCaa MD; Cochran MF; Konicki PE; Davis CS; Wilder C
    Subst Abus; 2016; 37(1):118-26. PubMed ID: 26675643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes.
    Williams AV; Marsden J; Strang J
    Addiction; 2014 Feb; 109(2):250-9. PubMed ID: 24103087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.
    Ling W; Casadonte P; Bigelow G; Kampman KM; Patkar A; Bailey GL; Rosenthal RN; Beebe KL
    JAMA; 2010 Oct; 304(14):1576-83. PubMed ID: 20940383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of lower-dose versus higher-dose intravenous naloxone on time to recurrence of opioid toxicity in the emergency department.
    Wong F; Edwards CJ; Jarrell DH; Patanwala AE
    Clin Toxicol (Phila); 2019 Jan; 57(1):19-24. PubMed ID: 30032680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose: A Cohort Study.
    Larochelle MR; Liebschutz JM; Zhang F; Ross-Degnan D; Wharam JF
    Ann Intern Med; 2016 Jan; 164(1):1-9. PubMed ID: 26720742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice trainees.
    Klimas J; Egan M; Tobin H; Coleman N; Bury G
    BMC Med Educ; 2015 Nov; 15():206. PubMed ID: 26590066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linking Opioid-Overdose Data to Human Services and Criminal Justice Data: Opportunities for Intervention.
    Hacker K; Jones LD; Brink L; Wilson A; Cherna M; Dalton E; Hulsey EG
    Public Health Rep; 2018 Nov; 133(6):658-666. PubMed ID: 30300555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Narratives of people who inject drugs on factors contributing to opioid overdose.
    Chang JS; Behar E; Coffin PO
    Int J Drug Policy; 2019 Dec; 74():26-32. PubMed ID: 31442677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of opioid overdose and response in a high-risk community corrections sample: a preliminary study.
    Cropsey KL; Martin S; Clark CB; McCullumsmith CB; Lane PS; Hardy S; Hendricks PS; Redmond N
    J Opioid Manag; 2013; 9(6):393-400. PubMed ID: 24481927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid overdose experiences in a sample of US adolescents and young adults: a thematic analysis.
    Monico LB; Ludwig A; Lertch E; Dionne R; Fishman M; Schwartz RP; Mitchell SG
    Addiction; 2021 Apr; 116(4):865-873. PubMed ID: 32770757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.